Company: SLDE
Filing Date: 2025-01-22
Form Type: DRS/A
Source: 0000950123-25-000502
Chunk: 178

Company: Slide Insurance Holdings, Inc.
Filing Date: 2025-01-22
Form: DRS/A
Chunk 178
---
               |     |                   | 07/13/2023 |     |             | 100,000 |     |               |      — |    |     |          | 100,000 | -9 |     |          | 7.59 |     |            | 07/12/2033 |     |                 |       — |     |     |              |         — |
|               |     |                   | 12/17/2024 |     |             |       — |     |               |      — |    |     |          |       — |    |     |          |    — |     |            | —          |     |                 | 100,000 | -10 |     |              | 5,852,000 |

| (1) | All option awards and stock awards listed in this table were granted pursuant to our Prior Plan, the terms of                                   
 which are described below and further under Note 24 Stock-based Compensation to our financial statements included elsewhere in this prospectus. |

| (2) | The remaining unvested and unexercisable shares underlying this option become vested and exercisable in equal                                                                                          
 monthly installments of 6,250 shares over a period of 9 months through September 13, 2025, subject to the named executive officer’s continued employment or service through each monthly vesting date. |

| (3) | The remaining unvested and exercisable shares underlying this option become vested and exercisable if a                                                       
 positive EBITDA for calendar 2025 is attained by the Company, subject to the named executive officer’s continued employment or service at such vesting event. |

| (4) | 50,000 shares underlying this option become vested and exercisable upon each of the following: (i) the                                                                                                                                    
 first occurrence of the launch of the Company in a new state; and (ii) positive EBITDA for calendar 2025 is attained by the Company, subject to the named executive officer’s continued employment or service at each such vesting event. |

| (5) | The shares underlying this option become vested and exercisable as to 5,000 shares subject to the option on                   
 March 1 of 2025 and 2026, subject to the named executive officer’s continued employment or service through each vesting date. |

| (6) | The shares underlying this option become vested and exercisable as to 10,000 shares subject to the option on             
 September 1